1. Home
  2. KBDC vs BVS Comparison

KBDC vs BVS Comparison

Compare KBDC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KBDC

Kayne Anderson BDC Inc.

HOLD

Current Price

$13.45

Market Cap

885.8M

Sector

N/A

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$14.17

Market Cap

982.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBDC
BVS
Founded
2021
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
885.8M
982.2M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
KBDC
BVS
Price
$13.45
$14.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$15.50
$14.00
AVG Volume (30 Days)
394.3K
624.9K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
13.16%
N/A
EPS Growth
N/A
163.46
EPS
0.85
0.52
Revenue
N/A
$568,087,000.00
Revenue This Year
$193.84
$7.52
Revenue Next Year
$9.00
$7.06
P/E Ratio
$15.86
$27.62
Revenue Growth
N/A
N/A
52 Week Low
$13.06
$6.26
52 Week High
$15.87
$15.89

Technical Indicators

Market Signals
Indicator
KBDC
BVS
Relative Strength Index (RSI) 47.39 60.17
Support Level $13.37 $8.21
Resistance Level $14.20 $14.92
Average True Range (ATR) 0.23 0.50
MACD 0.01 -0.10
Stochastic Oscillator 50.00 62.16

Price Performance

Historical Comparison
KBDC
BVS

About KBDC Kayne Anderson BDC Inc.

Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company, investing mainly in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation mainly through debt investments in middle-market companies.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: